The latest data from our Global PrEP Tracker and our HIV Prevention Resource Tracking Report shows progress in expanding access to oral PrEP, and positive trends in research and development funding for PrEP. This is good news as we know that research alone will not end the epidemic. Effective products must be paired with robust programs and services to deliver them—and these programs must be designed by and with the people who need them most. Dollars for the HIV response must go up, not down, to reach global targets and end the epidemic.
Hard won progress in expanding access to all PrEP products, detailed below, will not keep pace with global targets if a comprehensive, rights-based approach gives way under pressure from increasing stigma, anti-LBGTQIA+ laws or faltering investment.